Background: Hemodialysis (HD) is associated with adverse cardiovascular events after percutaneous coronary intervention (PCI). Although the ultrathin strut biodegradable polymer sirolimus-eluting stent (ultrathin strut BP-SES) has had better results in patients undergoing PCI compared with other drug-eluting stents (DES), its usefulness in HD patients is unknown.
Methods And Results: This study involved 286 lesions in 162 HD patients who underwent PCI with a DES between January 2018 and June 2022.
Objective: The association between a combined anaemia and renal failure index and 1-year prognosis of patients undergoing transcatheter aortic valve implantation (TAVI) is unexplored. We aimed to investigate a simple risk score in patients undergoing TAVI.
Methods: A total of 469 consecutive patients undergoing TAVI between 2015 and 2021 were enrolled.